Selection of the best therapy for BRAF-Mutated Melanoma: Impact of Tumor Heterogeneity on Biomarker Validation and the Role of Cellular Plasticity in Acquired Resistance to Therapy

Alba de la Puente

B·ARGO

This coffee talk will be held in person, but if you're unable to attend, you can join online.